Form D · Biotechnology
Therapeutic Neuromodulation Systems LLC
Metairie, LA · CIK 0002152054
Offering snapshot reported Sep 21, 2026 · SEC filing
- Reported sold
- $1.71M Offering amount: $5M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Oct 15, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 21, 2026 | Initial | $1,709,500 | No comparison | 29 | SEC filing |
| Sep 11, 2026 | Initial | $969,500 | No comparison | 33 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-598204
Source: Form D, filed Sep 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arnold Joseph Rougee | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4405 N I 10 Service W Suite 100
Metairie, LA, 70006
Phone: 866-667-7420
Metairie, LA, 70006
Phone: 866-667-7420